Viatris, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US92556V1061
USD
10.76
0.05 (0.47%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1239932,
    "name": "Viatris, Inc.",
    "stock_name": "Viatris, Inc.",
    "full_name": "Viatris, Inc.",
    "name_url": "stocks-analysis/viatris-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "10.76",
    "chg": 0.05,
    "chgp": "0.47%",
    "dir": 1,
    "prev_price": "10.71",
    "mcapval": "12,476.13",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P 500",
    "isin": "US92556V1061",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "10.46 M",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/viatris-inc-1239932-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Viatris, Inc. Experiences Revision in Stock Evaluation Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/viatris-inc-technical-trend-shifts-from-mildly-bullish-to-bullish-amid-stock-price-increase-3649033",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/ViatrisInc_technicaldot_3649033.png",
        "date": "2025-10-27 15:48:38",
        "description": "Viatris, Inc. has recently revised its evaluation amid fluctuating market conditions, with its stock priced at $10.35. The company has experienced significant volatility over the past year, with mixed technical indicators and varied performance compared to the S&P 500, reflecting both challenges and opportunities in the pharmaceutical sector."
      },
      {
        "title": "Viatris Stock Forms Golden Cross, Signaling Potential Bullish Breakout Ahead",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/viatris-stock-forms-golden-cross-signaling-potential-bullish-breakout-ahead-3571399",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/ViatrisInc_goldencross_3571399.png",
        "date": "2025-09-25 16:58:36",
        "description": "Viatris, Inc. has recently experienced a Golden Cross, indicating a potential shift in momentum. The stock rose 1.15% today, contrasting with the S&P 500's decline. However, Viatris's longer-term performance remains challenging, with significant declines over the past year and five years, suggesting caution for investors."
      },
      {
        "title": "Is Viatris, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-viatris-inc-technically-bullish-or-bearish-3547881",
        "imagepath": "",
        "date": "2025-09-20 20:05:07",
        "description": "As of 25 August 2025, the technical trend for Viatris, Inc. has changed from sideways to mildly bearish. The current stance is mildly bearish, driven by daily moving averages and a bearish monthly MACD. Weekly indicators show mixed signals with the MACD and KST bullish, while the Bollinger Bands indicate a mildly bullish stance. However, the overall weakness is reflected in the Dow Theory and OBV, both showing mildly bearish trends. \n\nIn terms of performance, Viatris has underperformed the S&P 500 across multiple periods, with a year-to-date return of -20.80% compared to the S&P 500's 12.22%, and a 1-year return of -17.14% against the S&P 500's 17.14%...."
      },
      {
        "title": "Is Viatris, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-viatris-inc-overvalued-or-undervalued-3544107",
        "imagepath": "",
        "date": "2025-09-20 18:38:01",
        "description": "As of 9 May 2024, the valuation grade for Viatris, Inc. has moved from expensive to risky, indicating a shift in perception regarding its market valuation. The company appears to be overvalued, as evidenced by a P/E ratio of 38, which is significantly higher than the peer Walgreens Boots Alliance, Inc. at -14.12. Additionally, Viatris has an EV to EBITDA ratio of 6.47 and a Price to Book Value of 0.67, suggesting that its market price does not adequately reflect its underlying asset value.\n\nIn comparison to its peers, Viatris's valuation metrics indicate a concerning position, particularly with a return on equity (ROE) of only 1.75% and a return on capital employed (ROCE) of 2.82%. Furthermore, the company's stock has underperformed relative to the S&P 500 across multiple time frames, with a year-to-date return of -20.80% compared to the S&P 500's 12.22%. This trend reinforces the notion that Viatris is cur..."
      }
    ],
    "total": 8,
    "sid": "1239932",
    "stock_news_url": "https://www.marketsmojo.com/news/viatris-inc-1239932"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}
stock newsNews and Views
stock-recommendationAnnouncement
Icon
No announcement available
stock-recommendationCorporate Actions
Corporate Actions
info
Icon
No corporate action available